Top compounds associated with response to LRRC9


Feature Type Standardized
Nominal ANOVA
mRNA OSI-906 CTRPv2 pan-cancer AAC 0.08 0.02
mRNA prochlorperazine CTRPv2 pan-cancer AAC 0.083 0.02
mRNA PD318088 CTRPv2 pan-cancer AAC -0.079 0.02
mRNA Vandetanib CTRPv2 pan-cancer AAC -0.082 0.02
mRNA salermide CTRPv2 pan-cancer AAC 0.1 0.02
mRNA BRD-K03536150 CTRPv2 pan-cancer AAC 0.082 0.02
mRNA LRRK2-IN-1 CTRPv2 pan-cancer AAC 0.081 0.02
mRNA alisertib:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.077 0.03
mRNA ML311 CTRPv2 pan-cancer AAC 0.072 0.03
mRNA selumetinib:UNC0638 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.077 0.03
Download CSV